Amwill Health Care IPO Details: Price, Dates & Financials
The Amwill Health Care IPO is a closed SME Bookbuilding offer (Fresh Capital-cum-Offer for Sale) that opened on 5 February 2025. The Amwill Health Care IPO closed on 7 February 2025, with an issue price of ₹111 per share. The Amwill Health Care IPO has a face value of ₹10 and a lot size of 1,200 shares. The Amwill Health Care IPO is listed on 12 February 2025. The Amwill Health Care IPO allotment was scheduled for 10 February 2025.
On the financial front, the Amwill Health Care IPO reported revenue of ₹23 crore for 30 Sep 2024, compared with ₹44 crore for 31 Mar 2024. The Amwill Health Care IPO PAT was ₹7 crore against ₹13 crore. The Amwill Health Care IPO net worth as of 30 Sep 2024 was ₹24 crore.
Always verify The Amwill Health Care IPO details and GMP data with the official offer document before investing in the Amwill Health Care IPO.
Financial Summary
Amount in ₹ Crores
Metric
30 Sep 2024
31 Mar 2024
31 Mar 2023
Total Assets
29
19
12
Revenue
23
44
30
PAT
7
13
3
Net Worth
24
17
5
Reserves
8
17
5
Amwill Health Care IPO Financials FAQs
Revenue of Amwill Health Care (Amount in ₹ Crores) — 30 Sep 2024: 23; 31 Mar 2024: 44; 31 Mar 2023: 30. Profit after tax (PAT) — 30 Sep 2024: 7; 31 Mar 2024: 13; 31 Mar 2023: 3.
Total assets — 30 Sep 2024: 29; 31 Mar 2024: 19; 31 Mar 2023: 12. Net worth — 30 Sep 2024: 24; 31 Mar 2024: 17; 31 Mar 2023: 5. Reserves & surplus — 30 Sep 2024: 8; 31 Mar 2024: 17; 31 Mar 2023: 5. (Amount in ₹ Crores)
The financials shown for Amwill Health Care IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
